Bristol-Myers Squibb is a global Biopharma company committed to a single mission: to discover, develop, and deliver innovative medicines focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis.Join us and make a difference. We hire the best people and provide them with a work environment that places a premium on diversity, integrity, collaboration and personal development. Through a culture of inclusion, we create a better, more productive work environment. We believe that the diverse experiences and perspectives of all our employees help to drive innovation and transformative business results.Bristol Myers Squibb is a global biopharmaceutical company committed to transforming patients’ lives through science. At the core of that mission are the talented individuals who contribute their “unique” skillsets to help us drive innovation and deliver truly life-changing drugs for our patients. As we continue to pursue that mission, we’re looking for talented professionals like you to join our team. What unique gene will you bring?Position PurposeThe Business Process Champion (BPC) represents the Business Controls Function (BCF) as a leader and subject matter expert in financial, operational and fraud risks in the Order to Cash (OTC) operations. This position reports directly to the Director, US Commercial BCF, and could be based in either Princeton, New Jersey, or Tampa Florida. This role will have responsibility for all Business Control Function global service level delivery with respect to the OTC cycle, interacting closely with line and senior management Business Process Owners (BPOs) in this critical area. The individual selected for this position will implement best practices and remain abreast of outside developments in this cycle, and serve as a business partner to leadership in these organizations. Duties & ResponsibilitiesGovernance & Stakeholder Engagement
Regularly engage with management in the OTC business processes to proactively identify and mitigate financial, operational and fraud risk, serving as subject matter in the end-to-end processes for this business cycle.
Maintain formal stakeholder engagement plan for relationship management with the key leaders in these processes.
Consult outside resources as necessary including trade groups and management consulting firms to remain abreast of technological and other developments in this business cycle in an effort to drive process improvement and simplification opportunities.
Deliver training and presentations to the BCF network and applicable business process personnel regarding significant changes in control in the cycle.
Sarbanes-Oxley Annual Section 404 & Quarterly Section 302 Sub-certification Activities
Proactively evaluate the OTC control environment to ensure the Company’s internal control standards are optimal, with appropriate financial and anti-fraud controls.
Meet with key business leaders in these functions to ensure the controls documentation accurately reflects current practices and procedures.
On a quarterly basis, evaluate out of period adjustments to the financial statements, control failures and Global Internal Audit & Assurance (GIA) observations for potential Sarbanes-Oxley (SOX) deficiency reporting. Respond promptly to all control deficiencies and recommend corrective action.
Promptly and thoroughly evaluate the financial magnitude and potential pervasiveness of all OTC internal control deficiencies and work with management to develop robust root cause and remedial action plans, tracked to completion.
Immediately escalate and participate in evaluation of any control deficiencies with indicia of fraud, bribery or corruption to senior BCF leadership and department subject matter experts, including preparing reports to senior management and the Audit Committee of the Board of Directors.
On quarterly basis and more frequently as required, work with BPOs to understand and evaluate changes in control environment for SOX reporting and compliance purposes. This includes review of shared service center activities in the Order to Cash cycle and with local commercial market BCF associate in the Company’s markets.
Prepare and deliver presentations on the status of control deficiencies to senior management and the Company’s external auditors.
Facilitate annual walk-throughs of internal controls for OTC cycle for the BCF’s management and the Company’s external auditors. Update process flows and related narratives as necessary.
Review Sarbanes-Oxley testing that our Service Provider performs and assess the quality of testing and related test conclusions auditors.
Contribute to SOX scoping and testing decisions annually, including quantitative and qualitative considerations such as history and trend of control deficiencies, changes in people, process, technologies, and similar considerations.
Financial, Operational & Fraud Risk Assessment
Collaborate with Business Process Owners in these critical cycles to prepare an annual risk assessment designed to address top-of-mind financial, operational and fraud risks. This risk assessment helps prioritize the BPC’s project work for the year and considers internal and external sources of risks.
Follow-up with BPOs to ensure prompt and thorough implementation of risk mitigation activities.
Oversee the Order to Cash elements of the BCF’s fraud risk assessment and contribute to content development (i.e., fraud risk scenarios and potential mitigating controls).
Monitor higher fraud risk areas identified in global risk assessment and review if mitigation actions are in place for risks that implicate the OTC cycle.
Present to BCF and other leadership on the results and status of issues identified in this risk assessment. Collaborate with BCF senior leadership to incorporate suggestions into risk management framework
Internal Audit Facilitation
Facilitate all GIA activities related to the OTC cycle audits, including attending meetings, understanding observations, interpreting policy and procedure, whether audit findings represent SOX deficiencies, and contributing to the development of innovative remediation and process improvement opportunities.
Follow-up with BPOs on all remedial activity in response to audit observations to ensure prompt and thorough completion, and sustainable control improvement.
Proactively prepare whitepapers describing the BCF’s position on significant changes in the Company’s internal control environment.
Review and comment upon service auditor reports annually, including benchmarking against BMS internal controls for any risk areas disclaimed in the report.
Assess controls impact of robotics process automation (RPA) initiatives in the OTC cycle.
Participate as a business partner to BPOs on special projects initiatives from a financial, operational and anti-fraud control perspective (e.g., systems implementations, simplification and efficiency opportunities, etc.).
Certified Public Accountant or equivalent required. Understanding of revenue recognition principles and pharmaceutical industry gross-to-net accounting desirable. Well-versed in the Sarbanes-Oxley Act and related PCAOB regulations. Appreciation of and ability to articulate key compliance risks facing global pharmaceutical industry desirable (e.g., FCPA, UK Bribery Act, US Anti-Kickback Statute, etc.).
Strong understanding of the COSO Framework, including the 2013 amendments related to fraud risk assessment.
7 to 10 years total professional experience in accounting, audit, finance and/or similar functions. Big four public accounting / consulting or similar experience required.
Ability to analyze and report on issues, financial magnitude and pervasiveness of control deficiencies with speed and accuracy must be a core competency.
Competency at identifying root cause and developing of creative and thorough remediation plan designed to ensure sustainable remediation.
Understanding of US GAAP and internal controls. Must be a subject matter expert in this area.
Experience in financial analysis and data analytics desirable.
Previous Finance department experience a plus (e.g., financial analysis, close responsibilities, financial system implementations, etc.).
Bachelor’s degree in accounting or other business concentration required.
Ability to manage multiple projects and competing priorities, while working independently with speed and accountability.
Business partner attitude and ability to collaborate with different functions, while maintaining objectivity.
Ability to work with and communicate to a range of technically and culturally diverse people.
Ability to establish formal relationships across functions and multiple levels of management to drive performance and improve process.
Strong written and verbal communication skills. Comfort presenting to senior level leadership on areas that present risk.
Strong, proven leader, influencer, change agent, and executive presence.
Ability to execute a solution in a confident and successful manner.
Opportunity to enhance understanding of the key financial, operational and fraud risks in the OTC cycle.
Opportunity to be part of a professional and high performing team of 80 professionals, that is continually evolving and reacting to the key, top-of-mind risks facing senior management and an integral contributor to the Company’s overall enterprise risk management program.
Develop the ability to impact and influence within the Company to deliver superior business results and protect shareholders.
Opportunity to gain international experience and exposure to the Company’s OTC risks across the globe.
Department's constant innovation and improvement projects provides exposure through special projects to various disciplines within enterprise risk management.
Opportunity as a member of the BCF to contribute to the long-term strategy and growth of the department.
Bristol-Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees the resources to pursue their goals, both at work and in their personal lives.Bristol-Myers Squibb is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status.